Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. [electronic resource]
Producer: 20111020Description: 507-15 p. digitalISSN:- 1433-6510
- Acute Kidney Injury -- drug therapy
- Albuminuria -- etiology
- Animals
- Aspartic Acid Endopeptidases -- antagonists & inhibitors
- Constriction
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Endothelin-Converting Enzymes
- Enzyme Inhibitors -- pharmacology
- Glomerulosclerosis, Focal Segmental -- etiology
- Hypertension -- chemically induced
- Kidney -- blood supply
- Kidney Failure, Chronic -- drug therapy
- Male
- Metalloendopeptidases -- antagonists & inhibitors
- NG-Nitroarginine Methyl Ester -- toxicity
- Nephrectomy
- Neprilysin -- antagonists & inhibitors
- Rats
- Rats, Wistar
- Reperfusion Injury -- complications
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.